MXPA06009296A - Composiciones para suministro de agentes hipnoticos a traves de la mucosa oral y sus metodos de uso. - Google Patents

Composiciones para suministro de agentes hipnoticos a traves de la mucosa oral y sus metodos de uso.

Info

Publication number
MXPA06009296A
MXPA06009296A MXPA06009296A MXPA06009296A MXPA06009296A MX PA06009296 A MXPA06009296 A MX PA06009296A MX PA06009296 A MXPA06009296 A MX PA06009296A MX PA06009296 A MXPA06009296 A MX PA06009296A MX PA06009296 A MXPA06009296 A MX PA06009296A
Authority
MX
Mexico
Prior art keywords
composition according
group
composition
salt
tablet
Prior art date
Application number
MXPA06009296A
Other languages
English (en)
Spanish (es)
Inventor
Singh N Nikhilesh
Original Assignee
Transoral Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transoral Pharmaceuticals Inc filed Critical Transoral Pharmaceuticals Inc
Publication of MXPA06009296A publication Critical patent/MXPA06009296A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA06009296A 2004-02-17 2005-02-16 Composiciones para suministro de agentes hipnoticos a traves de la mucosa oral y sus metodos de uso. MXPA06009296A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78311804A 2004-02-17 2004-02-17
US59862904P 2004-08-03 2004-08-03
PCT/US2005/005021 WO2005079761A1 (fr) 2004-02-17 2005-02-16 Compositions permettant d'administrer des agents hypnotiques dans la muqueuse orale et methodes d'utilisation

Publications (1)

Publication Number Publication Date
MXPA06009296A true MXPA06009296A (es) 2007-01-26

Family

ID=34890604

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06009296A MXPA06009296A (es) 2004-02-17 2005-02-16 Composiciones para suministro de agentes hipnoticos a traves de la mucosa oral y sus metodos de uso.

Country Status (7)

Country Link
AU (1) AU2005215782B2 (fr)
BR (1) BRPI0507733A (fr)
CA (1) CA2556450C (fr)
IL (1) IL177227A (fr)
MX (1) MXPA06009296A (fr)
NZ (1) NZ548856A (fr)
WO (1) WO2005079761A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0423800D0 (en) 2004-10-27 2004-12-01 Orexo Ab New pharmaceutical formulations
JP2008542299A (ja) * 2005-05-25 2008-11-27 トランセプト・ファーマシューティカルズ・インコーポレイテッド 真夜中不眠症の治療のための固体組成物およびその治療方法
EP2455076A1 (fr) * 2007-04-09 2012-05-23 Sepracor Inc. Compositions comprenant la desvenlafaxine pour leur utilisation dans le traitement des troubles respiratoires liés au sommeil
FR2968992B1 (fr) * 2010-12-16 2013-02-08 Sanofi Aventis Comprime pharmaceutique orodispersible a base de zolpidem
CN103919780B (zh) * 2012-12-26 2016-12-28 上海中西制药有限公司 镇静安眠制剂、其复方制剂、制备方法及药物组合物
MA53050B1 (fr) * 2018-10-08 2023-03-31 Troikaa Pharmaceuticals Ltd Solutions oromuqueuses de zolpidem ou sels pharmaceutiquement acceptables de celles-ci

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW444018B (en) * 1992-12-17 2001-07-01 Pfizer Pyrazolopyrimidines
US6005109A (en) * 1997-10-30 1999-12-21 Pflizer Inc. Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
US6624162B2 (en) * 2001-10-22 2003-09-23 Pfizer Inc. Imidazopyridine compounds as 5-HT4 receptor modulators

Also Published As

Publication number Publication date
CA2556450A1 (fr) 2005-09-01
AU2005215782B2 (en) 2011-04-21
CA2556450C (fr) 2013-08-06
BRPI0507733A (pt) 2007-07-10
IL177227A (en) 2013-05-30
IL177227A0 (en) 2006-12-10
WO2005079761A1 (fr) 2005-09-01
AU2005215782A1 (en) 2005-09-01
NZ548856A (en) 2009-10-30

Similar Documents

Publication Publication Date Title
US7658945B2 (en) Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
US8242131B2 (en) Methods of treating middle-of-the-night insomnia
US20080254101A1 (en) Pilocarpine compositions and methods of use thereof
US20120034300A1 (en) Stabilized zolpidem pharmaceutical compositions
CA2556450C (fr) Compositions permettant d'administrer des agents hypnotiques dans la muqueuse orale et methodes d'utilisation
US20070287740A1 (en) Compositions and methods of treating middle-of-the night insomnia
CA2816904A1 (fr) Compositions permettant d'administrer des agents hypnotiques dans la muqueuse orale et methodes d'utilisation
KR20160105935A (ko) 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법
AU2016203713A1 (en) Solid compositions and methods for treating middle-of-the night insomnia
AU2012238306A1 (en) Solid compositions and methods for treating middle-of-the night insomnia

Legal Events

Date Code Title Description
HC Change of company name or juridical status
FG Grant or registration